No announcement yet.

Breakthrough in multiple sclerosis research

  • Filter
  • Time
  • Show
Clear All
new posts

    Multiple sclerosis treatments gain legal favor
    Stem cell therapies could help the 3,100 persons affected in Oklahoma
    Monday, May 18, 2009 12:50 PM CDT

    OKLAHOMA CITY – Multiple sclerosis, an autoimmune disease with potentially debilitating effects, may be reversible with stem cell therapy, according to new findings published in The Lancet Neurology journal. In the study, 80 percent of patients with early-stage multiple sclerosis saw improvement in their symptoms after undergoing stem cell therapy with their own cells



      UK: Adult Stem Cells Reverse Symtoms of Multiple Sclerosis
      By Bob Ellis on June 10th, 2009

      Chalk up yet another success for adult stem cell therapy!

      According to the UK Telegraph, researchers in Britain have taken stem cells from a patient’s own body fat to stimulate the regrowth of tissue damaged by multiple sclerosis.

      Last year experts suggested that stem cell therapy could be a “cure” for MS within the next 15 years.

      Patients’ symptoms were still improving up to a year after the treatment, the new study shows.

      One, a 50-year-old man, who had suffered more than 600 painful seizures in the three years before treatment has not had a single one since the infusion of his own cells.

      Another patient’s ability to walk, run and even cycle are still improving 10 months after the therapy.

      Apparently there are a couple of studies underway, and the second one is also reporting excellent results:



        Stem Cell Therapeutics Corp.: Dr. Alan Moore Will Present the Company's Brain and Neural Regeneration Therapy for the Treatment of Stroke and Multiple Sclerosis at the 2009 Banff Venture Forum

        CALGARY, ALBERTA - (Marketwire - Oct. 2, 2009) - Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) announced that Dr. Alan Moore, President and CEO, will be presenting today at the Banff Venture Forum 2009, taking place in Banff, Alberta, October 1-2. Dr. Moore will be providing an overview of the Company's clinical and pre-clinical stage programs, including progress in the Phase IIb stroke trial with Drs. Steven C. Cramer of the University of California, Irvine and Michael D. Hill of the Foothills Hospital at the University of Calgary, as co-lead investigators; as well as its soon-to-commence multiple sclerosis ("MS") phaseII trial with prolactin, lead by Drs. Luanne Metz and Fiona Costello of the MS Clinic at the Foothills Medical Centre in Calgary, Alberta.



          Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment

          -Electromyogram (EMG) findings show improvement in conduction speed and latency

          -RNL Bio's stem cell therapy demonstrates effective outcomes
          SEOUL, Korea, Dec. 6 /PRNewswire/ -- RNL Bio Co., Ltd, ( a leading biopharmaceutical company specialized in adult stem cell therapeutics announced today that a 46-year-old female, Kang Sook Park's Multiple Sclerosis improved tremendously after receiving stem cell treatment. Park was suffering from MS (Multiple Sclerosis), an autoimmune disease that affects the central nervous system (brain and spinal cord).

          Multiple Sclerosis is a disease in which the nerves of the central nervous system degenerate. MS can cause problems with muscle control and strength, vision, balance, feeling, and thinking. MS is caused by damage to the myelin sheath, the protective covering that surrounds nerve cells. When the myelin sheath is damaged, nerve impulses slow down or stop responding. From the many symptoms of MS, numbness or abnormal sensation in any area is predominant.

          For the past 20 years, Park suffered from MS. For stem cell injection, she was admitted into Choyang Hospital of Regenerative Medicine in Yanji, China for three weeks. She received stem cells intravenously as well as intrathecally. The injections were given in five intervals -- a total of 1.2 billion cells.



            Study could hold key to MS treatment

            Study could hold key to MS treatment
            By Henry L. Davis
            News Medical Reporter
            Updated: December 19, 2009, 11:50 PM / 2 comments

            Buffalo researchers early next year expect to report the initial results of the first major study of a controversial new theory that multiple sclerosis is caused by blockages in the veins that drain the brain.
            If proven correct, the novel theory could overturn the current understanding of how to diagnose and treat a disabling and incurable disease that attacks the nervous system.

            Advocates of the new theory contend that angioplasty, the same procedure used to open clogged arteries around the heart, could repair the blockages.

            If so, it could change the lives of the 2.5 million people worldwide — 500,000 in the United States — with MS, many of whom are desperate for better therapies and intensely monitoring the work here.